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Comments on “The organization of pharmaceutical services 
by ‘health region’ in Brazil’s Unified Health System”
Abstract  This study aimed to describe and char-
acterize the pharmaceutical services provided in 
Brazil’s Unified Health System (SUS) from the 
point of view of the healthcare networks that are 
organized by region in the QualiSUS-Rede Proj-
ect. This was a cross-sectional study, with data 
collected from December 2013 to July 2015, in 
public health establishments that carried out de-
livery or warehousing of medications (n = 4,938), 
in 465 municipalites, and the Federal District, in 
43‘Health Regions’. The results show the existence 
of at least one management service supporting 
the health network, and warehousing of medica-
tions in all the regions (> 90%). It also showed 
the availability of at least one healthcare service, 
in healthcare locations, by pharmaceutical pro-
fessionals is irregular between the Regions, being 
highest in the Southeastern Region (74.3%), and 
lowest in the Northeastern Region (43.3%). The 
results underpine the need for effective structuring 
of pharmaceutical assistance in the SUS networks, 
overcoming the current restrictive vision of its ac-
tivities, which gives value almost exclusively to the 
logistical component of support to the network, to 
the detriment of the clinical component. It is also 
important to expand, and improve the quality of, 
the population’s access to medical drugs, and im-
prove the quality of the healthcare offered to users 
of the system.
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The challenge of combating fragmentation, and 
providing continuous health services in a fair and 
wide-ranging manner, continues to be a major 
imperative for the majority of the countries of 
the Americas1.
This challenge is more complicated in a coun-
try such as Brazil which, as well as its continen-
tal scale and very long frontier, lives with what is 
referred to as the “triple burden”. This situation 
obliges managers to seek care solutions giving 
special attention to the simultaneous growth of 
the external causes and of chronic diseases, prin-
cipally because of the significant aging of the pop-
ulation, while parasitic and infectious diseases, 
and malnutrition, typical of underdevelopment 
countries, continue to require attention and care2.
In this context, the regionalization of Brazil’s 
Unified Healthcare System (Sistema Único de 
Saúde, or SUS) is the major orienting axis of de-
velopment of this system for the coming decades. 
It is the result of coordinated action by the three 
federal entities involved in the implementation 
of constitution of Health Regions, in which re-
gional healthcare networks are organized3.
In Brazil, the Federal Government, the States 
and the municipalities are defined as territories 
by political-administrative division. They are 
thus constituted into territories in which health 
practices are organized. However, from the point 
of view of organization of healthcare networks, 
it is necessary to configure other territories, that 
correspond to the Health Regions. These are un-
derstood as being a geographical area that holds 
a population with singular epidemiological and 
social characteristics and its own healthcare 
needs, and also with health resources already ex-
isting within it to serve that population3,4. 
In the Health Regions, regional healthcare 
networks are organized based on complemen-
tarities and exchanges, and agreed in a participa-
tive manner between managers of municipalities 
and States. The modelling of these regional net-
works of healthcare in the SUS presents a group 
of challenges which need to be overcome for an 
integrated system to be consolidated that ensures 
the access and the healthcare quality offered. For 
this, there is a need for cooperation and a spirit of 
solidarity between states and municipalities and 
between municipalities of each Health Region5.
In 2010, guidelines were agreed in Brazil for 
structuring of the Healthcare Network (Rede de 
Atenção à Saúde, or RAS), which were defined as 
a strategy for overcoming the fragmentation of 
healthcare and management in the Health Re-
gions. They seek to optimize the political and 
institutional functioning of the SUS, aiming to 
ensure that the user gets the group of services 
that s/he needs, with effectiveness and efficiency6.
The Healthcare Networks can be understood 
as organizing arrangements of functional health 
units, either as care points or as diagnosis and 
therapy points, where procedures are carried out 
with different technological densities and which, 
when integrated through the logistics and man-
agement systems, seek to ensure integral health-
care in a given territory2. One of the fragilities 
that Rodrigues et al.7 encountered, in an integra-
tive review was lack of knowledge, on the part of 
primary healthcare professionals, of the various 
healthcare points. 
Pharmaceutical policies are one of the 
cross-sectional, strategic types of public policy 
for the process of structuring and organization 
of the RAS, and with it strengthening of primary 
healthcare.
Pharmaceutical services involve technical 
and management activities such as a Healthcare 
Support System, but above all activities of health-
care itself, and they should express commitment 
to direct support for the user and obtaining of 
health results. Effective structuring of the phar-
maceutical services in the RAS is a fundamental 
need, not only for widening and improving the 
population’s access to medical drugs, but also for 
improving the healthcare offered directly to users 
of the system2,8. This type of action has been and 
is being defended in Brazil by significant actors 
such as the Health Ministry9, and the Federal 
Pharmacies Council10.
This group of activities, articulated in the 
multi-professional and inter-sectorial actions, is 
also essential for ensuring access to quality med-
ical drugs, and promotion of their appropriate 
use8. A systematic review11 found that the major-
ity of the studies included pointed to the impor-
tance of the action of pharmaceutical profession-
als in the management of therapy, in advising the 
patient and in training of health professionals 
in the improvement of the process of care and 
achievement of clinical results.
However, as to significant advances in Bra-
zil’s pharmaceutical policies, it is recognized that 
there are still challenges to be faced in relation 
to the prospect of guaranteeing access to medi-
cal drugs and qualification of the pharmaceutical 
services provided to the population12,13.
Considering the phase of implantation of 








work towards adaptation of the pharmaceutical 
services in such a way that they can contribute to 
this strategy with all their potential.
This present study aims to characterize the 
pharmaceutical services provided in the SUS 
from the point of view of the Healthcare Net-
works in the Health Regions included in the 
QualiSUS-Rede Project.
Methods
This is an analysis of data from the survey ‘Phar-
maceutical Services in the Brazilian Healthcare 
Networks (RASs): an approach in the QualiS-
US-Rede regions’, which was carried out through 
a partnership established between the Ministry 
of Health and World Bank. The aim of the study 
was to identify the situation of the pharmaceu-
tical services, and management and healthcare 
techniques in the 15 priority Regions of the 
QualiSUS-Rede Project, in accordance with the 
guidelines proposed for the functioning of the 
Regional Healthcare Network (RAS). The Quali-
SUS-Rede was instituted as a strategy of support 
for organization of the RAS in Brazil, aiming to 
contribute to higher quality of care, management 
in health and management and development of 
technologies, through the organization of re-
gional and themed Healthcare Networks and im-
provement of quality of care in general. It com-
prises five strategy directives, the first of which 
is ‘Support for Structuring and Quality Improve-
ment of the RAS’14.
The study had a cross-sectional design, with 
data collected from December 2013 to July 2015 
in all the public health establishments that were 
carrying out local warehousing of medical drugs, 
in 485 municipalities and the Federal District, in 
43 Health Regions (http://sage.saude.gov.br/), 
which were part of the QualiSUS-Rede Regions in 
September 2013. The initial selection of the estab-
lishments was the National Health Establishments 
Registry (Cadastro Nacional de Estabelecimentos 
de Saúde – CNES) (http://cnes.datasus.gov.br/).
Five instruments were used for the collection 
of data: (1) a questionnaire to the Health Secre-
tary; (2) a questionnaire to the person responsi-
ble for Pharmaceutical Services; (3) a question-
naire to the person responsible for the healthcare 
point and/or the therapeutic support point; (4) a 
questionnaire for the person responsible for the 
Pharmaceutical Supply Center; and (5) a ques-
tionnaire to the person responsible for the Hos-
pital Pharmacy. The last three of these instru-
ments were accompanied by a ‘script’ of direct 
observation.
In this article the data from instrument 3 were 
used – this instrument included structured ques-
tions, relating to management, structure and ser-
vices offered in the establishment. It was applied 
by an interview of the persons responsible for the 
pharmacies of the following establishments: Pri-
mary Health Units/Health Centers/Health Posts, 
Psycho-social Care Centers (CAPSs), pharmacies 
of the prison system, and pharmacies in exclusive 
buildings (basic medical drugs/“live pharmacy”/
Popular Pharmacy/medical drugs of the special-
ized component).
The following were excluded from the analy-
sis: hospital pharmacies; and the municipal and 
State pharmaceutical supply centers – because 
they have different instruments due to their spe-
cific characteristics. 
The outcomes considered were the pharma-
ceutical services offered in the health establish-
ments considered to be pertinent to: (1) Health-
care Points (Pontos de Atenção à Saúde, or PASs) 
– when the establishment and the related sector 
or area identified had a pharmacist (as a technical 
responsible and/or assistant), and carried out at 
least one of the following Clinical Pharmaceuti-
cal activities: dispensing; pharmacotherapeutic 
follow-up; therapeutic guidance; pharmaco-
therapeutic review and pre/post-treatment drug 
comparison or drug surveillance activities; (2) 
Diagnosis and Therapy Support Points (Pontos 
de Apoio Diagnóstico e Terapêutico, or PADTs) 
– when the professional of the establishment and 
related sector or area identified said that they car-
ry out the delivery of the medical drugs in the 
establishment; (3) the Healthcare Network Sup-
port System (Sistema de Apoio a Rede de Atenção 
à Saúde, or SARAS), when the establishment 
stated that it in some way participates in at least 
one of the Technical Management Pharmaceuti-
cal Services of support to the network, and also 
local warehousing of medical drugs (selection/
programming/acquisition/distribution). The op-
erational definitions of the variables used in the 
study are described in Chart 1.
The independent variables investigated were: 
Administrative Region (North, Northeast, South-
east, South, and Southeast); number of health re-
gions and pharmaceutical services offered. The 
proportions were estimated, and Pearson chi-
squared tests were applied for evaluation of the 
statistical significance, considering significance 
level of 5%. The statistics program SPPS 18.0 was 











The study was approved by the National 
Ethics Research Committee (Comitê Nacional 
de Ética em Pesquisa, or Conep). All the inter-
views were preceded by signature of a Free and 
Informed Consent Form (TCLE).
Results
It was interviewed the persons responsible for 
pharmacies in 4,938 establishments that ware-
housed medical drugs, in 15 regions of the Qual-
iSUS-Rede Project. A great majority (79%) were 
Health Centers/Health Units/Health Posts, locat-
ed in 465 municipalities and the Federal District, 
belonging to 43 Health Regions in the period of 
the data collection. The percentage of loss was 
4.1%, corresponding to 20 municipalities, due to 
problems in storage of the data.
Figure 1 gives the characterization of the 
sample in terms of the proportion of Health Re-
gions, municipalities and establishments by Ad-
ministrative Region. Approximately one-third of 
the establishments (n = 1,773) and of the mu-
Chart 1. Operational definition of the pharmaceutical service activities considered in the study, QualiSUS-Rede. 
Brazil, 2015.
Service Operational definition
Service supplied in Healthcare Points (PASs)
Dispensing of drugs The establishment has a pharmacist, and this pharmacist reported delivering 
drugs always together with therapeutic guidance.
Therapeutic guidance The establishment has a pharmacist, and this pharmacist reported giving 
therapeutic guidance with delivery of the medication and/or in group 
activities.
Pharmacotherapeutic follow-up The establishment has a pharmacist and this pharmacist reported making 
pharmacotherapeutic follow-up.
Therapeutic conciliation The establishment has a pharmacist and this pharmacist reported carrying 
out therapeutic conciliation.
Pharmacotherapeutic review The establishment has a pharmacist and this pharmacist reported making 
pharmacotherapeutic review.
Drug surveillance In the establishment the person responsible reports carrying out 
notification of complaints and/or adverse reactions to drugs 
Service carried out at the Diagnosis and Therapy Support Points (PADTs)
Drug delivery Delivery of drugs in the establishment was carried out by a non-pharmaceutical 
professional and with therapeutic guidance to the user.
Management services as Healthcare Network Support System (SARAS) 
Selection of drugs The pharmacist of the establishment or referral pharmacist reports 
participating in the process of selection of drugs; and/or: the person 
responsible for the pharmacy reports that activities carried out in the 
establishment include request for inclusion/exclusion of drugs in/from the 
municipality’s standard list of drugs, and that list was made available to the 
health professionals and in the consulting offices of the persons prescribing.
Programming of drugs The establishment’s pharmacist reports participating in the programming 
of drugs, and/or where the person responsible for the pharmacy reported 
that there is in the establishment a timetable for sending of information for 
programming of acquisition of drugs and a timetable for sending of request 
for supply of the units to Pharmaceutical Central Supply (CAF).
Acquisition of drugs The establishment’s pharmacist reports participating in the acquisition of 
drugs.
Warehousing of drugs Considered to be a criterion for inclusion in the study when there is 
warehousing of drugs in the establishment.
Distribution of drugs The establishment’s pharmacist or referral pharmacist reports distribution of 









nicipalities (n = 146) are in the Northeastern 
Region, and the Southeast was the Region with 
the highest proportion of health regions (n = 13), 
with all municipalities included in the study.
The great majority (78.0%) of the establish-
ment had the participation of a pharmacist. The 
supply of pharmaceutical services by professional 
was analyzed in these 3,377 health service points. 
The service with the largest supply in the estab-
lishments was therapeutic guidance, individual-
ly or in groups (44.5%), followed by dispensing 
(33.5%), and there was a low level of realization 
of pharmacotherapeutic follow-up of the pa-
tients (7.1%). The services of therapeutic concili-
ation (pre/post-treatment drug comparison) and 
pharmacotherapeutic review were not reported 
in any of the establishments visited. It was nota-
ble that it was in the Southeastern Region that we 
found the largest proportion of establishments 
with the health services offered at the healthcare 
points, while the lowest supply was found in the 
Northeastern Region (Table 1).
Drug surveillance service was reported in a 
quarter of the establishments (24.2%), taking 
Table 1. Proportion of establishments with supply of Pharmaceutical Services at Healthcare Points (PASs) and 
at Diagnosis and Therapy Support Points (PADTs) in the QualiSUS-Rede regions, by administrative region and 














N % N % N % N % N % N %
Services in PASs
Drug surveillance* 36 7,5 432 24,4 307 34,5 303 24,0 113 21,9 1191 24,2
Clinical pharmaceutical 
services
Dispensing of drugs 139 48,6 174 14,2 196 27,0 649 59,1 94 23,6 1252 33,5 ≤ 0,001
Therapeutic guidance 151 52,8 324 26,5 307 42,2 750 68,2 128 32,1 1660 44,5
Pharmacotherapeutic 
follow-up 
22 7,7 19 1,6 38 5,2 168 15,3 18 4,5 265 7,1
Service in PADTs**
Drug delivery 174 36,0 1133 63,9 516 57,8 788 61,9 346 66,9 2957 59,9 ≤ 0,001
* Calculated only for the establishments that had a pharmacist (n = 3,733). ** Calculated using the total of establishments visited 
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Figure 1. Characterization of the sample as to the proportion of Health Regions, Municipalities and Establishments 
by Administrative Region. QualiSUS-Rede Regions, Brazil, 2015.


















place in the highest proportion in the establish-
ments of the Southern Region (34.5%), and in 
the lowest proportion in the establishments of 
the Northern Region of the country (7.5%).
Although the great majority of the estab-
lishments (86.0%) reported delivery of medical 
drugs by other professionals than the pharma-
cists (data not presented in a table), only 60% 
carried out this delivery with therapeutic guid-
ance to the user. This proportion was greatest 
in the Center-West Region (66.9%) and North-
east (63.9%) and lowest in the Northern Region 
(36.0%) (Table 2).
As to the establishments that participate in 
the Pharmaceutical Management services, in the 
form of the Healthcare Network Support System 
(SARAS) in the regions, it was noted that the 
great majority of them reported participation in 
the programming services (83.8%) and services 
of selection of medical drugs (79.5%).
Comparing the administrative regions of the 
country: a greater participation in the selection 
of medical drugs in the establishments was re-
ported in the Southern Region (88.7%); and of 
programming in the Southeastern (88.8%) and 
Southern (88.2%) Regions. There was a low par-
ticipation in the processes of acquisition and dis-
tribution of medical drugs to other health service 
points in general, with the largest proportion in 
the Southeastern Region, 22.3% for acquisition 
and 35.1% for distribution.
Table 3 shows the distribution of the number 
of health regions, population and proportion of 
supply of pharmaceutical services in the health 
Table 2. Proportion of establishments that take part in management Pharmaceutical Services as part of the 
Healthcare Network Support System (SARAS) in the Health Regions included in the QualiSUS-Rede Regions, by 
Administrative Region and QualiSUS-Rede Region. Brazil, 2015.
















N % N % N % N % N % N %
Selection of drugs 300 62,9 1365 77,8 787 88,7 1031 83,5 368 75,6 3851 79,5 ≤0,001
Programming of drugs 362 75,9 1431 80,8 784 88,2 1123 88,8 421 81,6 4121 83,8
Acquisition of drugs 18 3,7 130 7,3 67 7,5 284 22,3 14 2,7 513 10,4








PASs** PADTs*** SARAS*** Valor p
n % n % n %
Northern Region 08 4.064.276 161 56,3 174 36,0 442 92,5 ≤ 0,001
Northeast Region 12 8.911.847 528 43,3 1.133 63,9 1.653 93,5
Southern Region 05 8.364.871 420 57,9 516 57,8 869 97,4
Southeast Region 13 19.430.288 815 74,3 788 61,9 1.247 98,9
Mid-West Region 05 4.652.706 186 46,7 346 66,9 476 93,9
Total 43 45.423.988 2.110 56,6 2.957 59,9 4.687 95,6
* Population according to IBGE. ** Proportion of establishments that have a pharmacist and offer at least one clinical service in the 
PASs in the administrative region (n = 3,377). *** Proportion of establishments that offer at least one pharmaceutical service in the 
PADTs and at least one other than warehousing while acting as SARAS in the administrative region (n = 4,938).
Table 3. Distribution of the number of Health Regions, population and proportion of supply of pharmaceutical 
services in Healthcare Points (PAS), Diagnosis and Therapy Support Points (PADTs) and Healthcare Network 








establishments in Healthcare Points (PASs), Di-
agnosis and Therapy Support Points (PADTs) 
and the Healthcare Network Support System 
(SARAS), by Administrative Region. The total 
population of the 43 health regions included in 
the QualiSUS-Rede Project totals approximately 
45 million people who may be benefited by the 
supply of services of the healthcare network, 
with a highlight for the 13 Health Regions of the 
Southeastern Region, with approximately 20 mil-
lion people. 
It was found that there was at least one man-
agement service in support of the healthcare net-
work – in addition to the storage of medications 
– in all the regions (> 90%). Supply of at least one 
assistance service at the care points was found to 
be irregular between the Regions: in the greatest 
proportion in the Southeastern Region (74.3%); 
and in the lowest proportion in the Northeastern 
Region (43.3%).
Discussion
This study provided an evaluation which, from 
the regional point of view was unprecedented, 
of both management and care pharmaceutical 
services provided in health establishments con-
nected to the SUS in the regions covered by the 
QualiSUS-Rede Project. Attention can be drawn 
to the complexity of the sample, and the pop-
ulation coverage, of more than 45 million in-
habitants distributed over 485 municipalities in 
the Federal District, belonging at the time to 43 
health regions and 17 units of the Brazilian Fed-
eration of States.
The results obtained in this study should be 
considered as input material to help in perfect-
ing the pharmaceutical services provided within 
the SUS, in terms of better responding to today’s 
health needs in the context of the structural and 
functional challenges of the regional network. 
It is known that the situation of needs in health 
is changing, calling for decisions on a group of 
strategies to achieve integration of the SUS in all 
its dimensions.
The survey showed greater participation in 
the services of programming and selection of 
medications at establishments that took part in 
the Pharmaceutical Management services in the 
form of the Healthcare Network Support System 
(SARAS) in the regions; but there was low partic-
ipation in the processes of acquisition and distri-
bution of medical drugs to other care points. This 
could be the result of a trend to centralization of 
management services, and low participation in 
the integrated planning of pharmaceutical care 
– which in turn could cause supply gaps for the 
healthcare network, with low availability of drugs 
occurring in Primary Health Units13.
The supply of clinical services provided by 
the pharmacist was identified, by Region, on the 
basis of what is specified in the framework of the 
RASs, grouping the results in accordance with 
whether the health establishment was classified 
as a Healthcare Points (PAS) and/or as a Diagno-
sis and Therapy Support Points (PADT). Accord-
ing to Lavras3, the PASs that comprise the RAS 
are functional units, which call for differentiated 
and specific technological conditions (physical 
structure, equipment and inputs, profile of the 
professional staff, specific technical knowledge) 
and a well-defined field of activity, for supply of 
a group of health actions. The PADTs are also 
functional units, but ones that offer support pro-
cedures such as: diagnosis by image, pathology 
and clinical analyses, chart/graphic methods, de-
livery of drugs, etc.
Provision of pharmaceutical clinical services 
was shown to be inconsistent across the adminis-
trative regions of the country. 
The activity of dispensing can be defined as 
an action carried out by a pharmaceutical profes-
sional for the purpose of providing medical drugs 
and orientation for their rational use, in response 
to the presentation of a prescription prepared by a 
professional15. A consensus has grown in Brazil of 
designating as ‘delivery of drugs’ any action that 
involves the supply of medical drugs directly to 
user, but does not comply with all the conditions 
in the above definition, especially that of realiza-
tion by a pharmaceutical professional16. The sup-
ply of dispensing services was low in the health 
regions investigated, even when the pharmacist 
was present, and, in a great majority of the es-
tablishments, what was reported was delivery by 
other non-pharmaceutical professionals without 
orientation being given to the user. Gaps in the 
qualification of pharmacists for activities of dis-
pensing, and the non-understanding of the role 
of the pharmacist in clinical activities directly 
by the user by the community and also by other 
healthcare professionals, provide reasons that are 
frequently referred to for the delivery of drugs 
being the responsibility of other professionals, as 
indicated in a study in Malaysia17.
It can be highlighted that this result can point 
to gaps in the organization of the services and 
qualification of the professionals for carrying out 











health actions in the healthcare network, which 
should have elements of orientation, and promo-
tion, to the population, of rational use of drugs.
Also incipient was any reporting of pharma-
cotherapeutic follow-up of the patients in the 
Health Regions and there was no reference to 
the supply of services of pre/post-treatment drug 
comparison and pharmacotherapeutic review. 
Evidence has demonstrated the impact of clinical 
services for the community18,19. The purpose of 
pharmacotherapeutic monitoring/follow-up of 
users, and pharmacotherapeutic review, is eval-
uation of the medical drugs used by patients, 
prescribed and not prescribed, for the purpose of 
identifying drug interactions, or low levels of ad-
herence to treatment, such as might be compro-
mising the therapeutic results. The therapeutic 
conciliation (comparison of the drugs prescribed 
after discharge from hospital with those that 
were being used by the patient before the hos-
pital admission), including those prescribed by 
the primary healthcare doctors, aims to propose 
solutions to the user and to the team for harmo-
nization of the patient’s care plan9.
It needs to be highlighted that the clinical ac-
tivity of the pharmacist should be integrated with 
the health team for the achievement of optimum 
results, and inter-professional barriers in the in-
tegration of pharmacists into the primary health-
care team need to be overcome, as was pointed 
out in a study made in England20. Integration of 
the actions of the various professionals is funda-
mental for guaranteeing maximum effectiveness 
and minimum risk in therapies. For this, it needs 
to be integrated coordination of the decisions in 
pharmacotherapeutic care of users, so as to facil-
itate care continuity in the care network21.
The Northeast and Center-West regions stood 
out from the others for a low level of supply of 
services of dispensing, therapeutic guidance and 
pharmacotherapeutic follow-up. However, these 
regions presented the highest proportional sup-
ply of the service of diagnostic and therapeutic 
support. This situation both (i) reflects the short-
age of professionals, and also (ii) raises questions 
on the qualifications of the pharmacists that car-
ry out clinical functions in the establishments, 
and the process of training of those professionals. 
It is also in our view related to the distribution of 
work time/working hours – which has the effect 
of causing them to give priority to the technical 
and management activities carried out to sup-
port the network.
This reaffirms the need for greater discus-
sion on the importance of a qualified supply of 
clinical services, able to respond better to users’ 
health needs, and to overcome issues related only 
to access and to the quality of the pharmaceuti-
cal products made available. This requires action 
articulated with the process of healthcare able to 
ensure continuity of care, and also prevention 
and resolution of problems related to pharmaco-
therapy1. Various authors8,23-25 have agreed on the 
great challenges involved in the implementation 
of pharmaceutical services, giving priority to the 
need for healthcare, from basic healthcare to spe-
cialized healthcare, with a focus on people – fam-
ily and community – replacing the focus on the 
medical drugs as merchandise.
The majority of the services investigated in 
this study were in basic healthcare – in which 
the Pan-American Health Organization8 argues 
that the provision of pharmaceutical services is 
a key element, especially in that it involves for 
the direct relationship with the user/patient. 
This activity includes: health promotion, dis-
pensing, pharmacotherapeutic accompaniment/
follow-up, drug surveillance, and support for 
responsible self-medication. The list of services 
investigated includes some addressed to groups 
in various situations of vulnerability, such as the 
pharmacies of the CAPSs, of the prison system or 
those of the specialized component – situations 
in which there are users with differentiated care 
requirements.
Health establishments or posts providing Di-
agnostic and Therapeutic Support were found 
to be in the same proportion as those supply-
ing clinical services. However a point that calls 
attention, and should be emphasized, in relation 
to the regional organization of the services to be 
offered and the quality of the service of delivery 
or supply of drugs to the user, is that the majority 
of the healthcare posts and/or therapeutic sup-
port posts report the delivery being carried out 
by non-pharmaceutical professionals.
Finally, it should be highlighted that the pro-
cess of systemic integration which is being pur-
sued in the SUS also calls for integration in the 
dimensions of both health services and profes-
sional practices. In this aspect, there is a need to 
decide on a group of initiatives directed toward 
qualification, organization and integration of 
structures or processes related to these services 
and to the professional practices that are carried 
out within them26.
From this perspective, even though there have 
been a group of significant advances in pharma-
ceutical services in the SUS, one must recognize 








pect of guaranteeing quality, accesses, and stimu-
lus for the rational use of medical drugs26.
The programming of actions and services in 
the regions, especially for the clinical services, 
should be thought out, programmed and offered 
based on the needs of the population actually in 
the territory, based on the epidemiological and 
nosological data and profiles and obeying the 
existing capacity of establishments, such as phar-
macies27.
Effective structuring of Pharmaceutical Ser-
vices in the RASs is a fundamental need, not only 
for expanding and qualifying the population’s 
access to drugs, but also to improve the quality 
of the healthcare directly offered to users of the 
system. For this, there is a need to overcome a re-
strictive vision of the activities of pharmaceutical 
care – which habitually gives value almost exclu-
sively to its logistical component, to the detri-
ment of the clinical pharmaceutical component26.
Pharmaceutical Services should be under-
stood to mean a group of activities that could be 
characterized as: Support to the Regional Health-
care Networks (RRAS) – related to supply; Ther-
apeutic Support – delivery of drugs; Pharmaceu-
tical Care – related to education in health; and 
Pharmaceutical Clinical Practice per se. Among 
the highlights are the activities of drug surveil-
lance, and those carried out through individual 
or shared consultations, which are essential in the 
process of facing the chronic conditions.
It is known that the clinical handling of these 
conditions calls for not only continuity of care 
and integration of multi-professional work, but 
also a differentiated activity of each professional, 
which in the case of the pharmacist should con-
centrate as priority on the co-morbidities; multi-
drug patients; and/or those with low acceptance 
of use of drugs.
We agree with Lavras3, Mendes et al.13, 
Mendes24 e Magalhães Júnior et al.28 that this re-
gional organization of the health system and the 
logic of the RASs needs to attend to the various 
situations of models, and not only a regionaliza-
tion linked to containment of the use of services, 
to avoid costs arising from transfers between the 
regions29.
It should be able to overcome the factors that 
perhaps most interfere in formation and consol-
idation of the RRAS, which are the fragmenta-
tion of services, and the absence, or fragile artic-
ulation, between its various healthcare posts in 
their different levels of activity. Pharmaceutical 
services, which are also in a fragile state and are 
normally removed from this process of construc-
tion of the healthcare network in the territory, 
are included in this case. 
Thus, proposing the characterization of the 
activities related to Pharmaceutical Services as 
inherent to the PASs; to the PADTs; and also as 
part of the SARAS as a whole, whether or not 
coexisting in a single establishment, widens the 
understanding of the different natures of these 
activities. Attention is drawn to the need to val-
ue the activities related to pharmaceutical care 
so as to better respond to the population’s health 
needs, inserting them clearly as activities specif-
ic to the functional units of the healthcare net-
works.
Finally, it can be emphasized that the guide-
lines agreed in 2010 for the RAS6 – which de-
scribe the pharmaceutical services only as part of 
the Support System, and as part of the so-called 
Pharmaceutical Services System, which involves 
the organization of this service in all its phases: 
selection, programming, acquisition, storage, 
distribution, prescription, dispensing and pro-
motion of rational use of drugs – need to be re-
defined on the basis of this evidence obtained in 
the QualiSUS-Rede Project.
As a limitation of the study we can highlight 
that absence, in the questionnaire, of a ques-
tion that explicitly identifies the process of pre/
post-treatment drug comparison and pharma-
cotherapeutic review as a record of the clinical 
services for establishment of health could be a 
limiting factor. The data on these services were 
captured through open questions, which could 
have contributed to their low degree of mention 
by interviewees. It is also possible that lack of 
knowledge or difference of understanding of the 
services about which the questions were asked 
may have influenced the findings.
The results underline the need for effective 
structuring of Pharmaceutical Services in the 
RAS, overcoming a restrictive vision of the ac-
tivities of pharmaceutical service, which almost 
exclusively gives value to its logistical component 
to the detriment of its clinical component – to 
expand and increase the quality of the popula-
tion’s access to drugs, and increase the quality of 
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